Tumor News and Research

RSS

Research offers explanation for ineffectiveness of checkpoint immunotherapy against bladder cancer

New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

25 Jul 2017

Study reveals effectiveness of neoadjuvant chemotherapy in triple-negative breast cancer

Researchers analyzed data confirming the improved outcomes in both short- and long-term survival in patients that underwent neoadjuvant chemotherapy prior to surgery for triple-negative breast cancer.

25 Jul 2017

Researchers discover mechanism that plays key role in development of resistance to immunotherapy

In tumor immunotherapy, the body's own defense system is activated against the tumor cells. However, for the majority of patients, the tumor cells become resistant to the treatments used.

25 Jul 2017

Study may have important implications for treatment of heart attacks and cancer

A new discovery by University of Bristol scientists helps to explain how cells which surround blood vessels, called pericytes, stimulate new blood vessels to grow with the hormone 'leptin' playing a key role.

25 Jul 2017

Neuro-oncology scientists discover unique molecular mechanism that maintains glioma stem cells

Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy, and radiation.

25 Jul 2017

Researchers understand how to prevent severe weight loss in cancer patients

Many cancer patients are susceptible to potentially lethal weight loss. Now researchers understand better why this happens, and perhaps how to prevent the condition.

25 Jul 2017

Wistar scientists discover new therapeutic strategy for difficult-to-treat form of ovarian cancer

A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

24 Jul 2017

NETRF announces new research grants to advance treatments for neuroendocrine tumors

The Neuroendocrine Tumor Research Foundation has announced a new round of scientific and clinical research grants, aimed at advancing the treatment of and the search for cures to neuroendocrine tumors.

21 Jul 2017

New genomic research partnership promises to redefine and transform cancer treatment

Personalized cancer therapies are on the horizon thanks to a new genomic cancer research partnership between the Gene Editing Institute of Christiana Care Health System's Helen F. Graham Cancer Center & Research Institute and the biotechnology company NovellusDx.

21 Jul 2017

Researchers devise strategy to target Achilles heel of nervous system cancers

Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment.

21 Jul 2017

Advanced lung cancer patients get survival benefit with use of concurrent chemotherapy, proton therapy

For patients with advanced, inoperable stage 3 lung cancer, concurrent chemotherapy and the specialized radiation treatment, proton therapy, offers improved survival compared to historical data for standard of care, according to a new study from The University of Texas MD Anderson Cancer Center.

20 Jul 2017

Study: Response to combination immunotherapy in melanoma depends on proportion of immune cells

Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco researchers joined by physicians from UCSF Health.

20 Jul 2017

Study identifies new mutations linked to hereditary neuroendocrine tumors

Pheochromocytomas and paragangliomas are rare neuroendocrine tumors with a strong hereditary component. Half the genes whose alterations confer hereditary susceptibility to develop this condition code for enzymes involved in the Krebs cycle, a metabolic route involved in cellular respiration.

20 Jul 2017

Engineered macrophages invade and engulf tumor cells in mouse models

One reason cancer is so difficult to treat is that it avoids detection by the body. Agents of the immune system are constantly checking the surfaces of cells for chemical signals that say they belong, but cancer cells express the same chemical signals as healthy ones.

19 Jul 2017

CU Boulder study sheds new light on mechanism behind radiation-induced bystander effect

More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells.

19 Jul 2017

New study shows how social interaction impacts treatment response in cancer patients

How well cancer patients fared after chemotherapy was affected by their social interaction with other patients during treatment, according to a new study by researchers at the National Human Genome Research Institute, part of the National Institutes of Health, and the University of Oxford in the United Kingdom.

19 Jul 2017

Scientists unlock secrets of indestructible virus to create super-durable materials

It's like the Superman of viruses, astonishingly tough and able to survive in an environment that would dissolve flesh and bone. And now scientists have unlocked the secrets of its indestructibility, potentially allowing them to harness its remarkable properties to create super-durable materials and better treat disease.

19 Jul 2017

Tumor News and Research

Research offers explanation for ineffectiveness of checkpoint immunotherapy against bladder cancer

Study reveals effectiveness of neoadjuvant chemotherapy in triple-negative breast cancer

Researchers discover mechanism that plays key role in development of resistance to immunotherapy

Study may have important implications for treatment of heart attacks and cancer

Neuro-oncology scientists discover unique molecular mechanism that maintains glioma stem cells

Researchers understand how to prevent severe weight loss in cancer patients

Wistar scientists discover new therapeutic strategy for difficult-to-treat form of ovarian cancer

NETRF announces new research grants to advance treatments for neuroendocrine tumors

New genomic research partnership promises to redefine and transform cancer treatment

Researchers devise strategy to target Achilles heel of nervous system cancers

Advanced lung cancer patients get survival benefit with use of concurrent chemotherapy, proton therapy

Study: Response to combination immunotherapy in melanoma depends on proportion of immune cells

Study identifies new mutations linked to hereditary neuroendocrine tumors

Engineered macrophages invade and engulf tumor cells in mouse models

CU Boulder study sheds new light on mechanism behind radiation-induced bystander effect

New study shows how social interaction impacts treatment response in cancer patients

Scientists unlock secrets of indestructible virus to create super-durable materials

Study shows how cancer cells force normal cells to act like viruses to enable tumor growth

Scientists discover how CD44s molecule gives brain cancer cells a survival advantage

Two cell types partner to protect pancreatic tumors from immune attack

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News